Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap24.34B
Enterprise Value23.33B
P/E Ratio20.29
PEG Ratio-1.89
Price/Sales Ratio3.64
Price/Book Ratio2.64
Enterprise/Revenue3.51
Enterprise/EBITDA15.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.18
Operating Margin0.19
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.13

Income Statement

Revenue5.85B
Revenue/Share6.06
Gross Profit4.04B
EBITDA1.44B
Net Income1.06B
Diluted EPS1.05

Balance Sheet

Total Cash3.74B
Total Cash/Share3.71
Total Debt415.13M
Total Debt/Equity0.05
Current Ratio6.22
Book Value Per Share8.33

Price History

52-Week Change-11.85
52-Week High29.3
52-Week Low17.96
Moving Average 50 Days20.7
Moving Average 200 Days22.45

Statistics

Average Volume12.21M
Shares Outstanding1.02B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield1.82
Payout Ratio0.7
Last Split Factor8:5
Last Split DateMay 12, 2017
AD